Protagonist Therapeutics, Inc. PTGX
NASDAQ · United States · Health Technology
$139.19-1.70 (-1.21%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 2.29 | 2.21 | +3.5% | $213.48M | +7.5% | +7.6%$135.81→$146.18 |
| Q1 2026 | 2026-05-05 | 0.05 | -0.65 | +107.7% | — | — | +4.5%$99.52→$103.97 |
| Q4 2025 | 2026-02-25 | -0.69 | -0.54 | -27.8% | — | — | +1.1%$87.39→$88.39 |
| Q3 2025 | 2025-11-06 | -0.62 | -0.59 | -5.1% | — | — | +2.1%$77.88→$79.54 |
| Q1 2025 | 2025-05-06 | -0.19 | 0.11 | -272.7% | — | — | — |
| Q4 2024 | 2025-02-21 | 1.98 | 0.25 | +692.0% | — | — | — |
| Q1 2024 | 2024-05-07 | 3.26 | 1.60 | +103.7% | — | — | — |
| Q4 2023 | 2024-02-27 | 0.44 | -0.18 | +344.4% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.